Endocannabinoid system: Role in blood cell development, neuroimmune interactions and associated disorders

dc.contributor.author Sharma, Durga Shankar
dc.contributor.author Paddibhatla, Indira
dc.contributor.author Raghuwanshi, Sanjeev
dc.contributor.author Malleswarapu, Mahesh
dc.contributor.author Sangeeth, Anjali
dc.contributor.author Kovuru, Narasaiah
dc.contributor.author Dahariya, Swati
dc.contributor.author Gautam, Dushyant Kumar
dc.contributor.author Pallepati, Aditya
dc.contributor.author Gutti, Ravi Kumar
dc.date.accessioned 2022-03-27T04:52:17Z
dc.date.available 2022-03-27T04:52:17Z
dc.date.issued 2021-04-15
dc.description.abstract The endocannabinoid system (ECS) is a complex physiological network involved in creating homeostasis and maintaining human health. Studies of the last 40 years have shown that endocannabinoids (ECs), a group of bioactive lipids, together with their set of receptors, function as one of the most important physiologic systems in human body. ECs and cannabinoid receptors (CBRs) are found throughout the body: in the brain tissues, immune cells, and in the peripheral organs and tissues as well. In recent years, ECs have emerged as key modulators of affect, neurotransmitter release, immune function, and several other physiological functions. This modulatory homoeostatic system operates in the regulation of brain activity and states of physical health and disease. In several research studies and patents the ECS has been recognised with neuro-protective properties thus it might be a target in neurodegenerative diseases. Most immune cells express these bioactive lipids and their receptors, recent data also highlight the immunomodulatory effects of endocannabinoids. Interplay of immune and nervous system has been recognized in past, recent studies suggest that ECS function as a bridge between neuronal and immune system. In several ongoing clinical trial studies, the ECS has also been placed in the anti-cancer drugs spotlight. This review summarizes the literature of cannabinoid ligands and their biosynthesis, cannabinoid receptors and their distribution, and the signaling pathways initiated by the binding of cannabinoid ligands to cannabinoid receptors. Further, this review highlights the functional role of cannabinoids and ECS in blood cell development, neuroimmune interactions and associated disorders. Moreover, we highlight the current state of knowledge of cannabinoid ligands as the mediators of neuroimmune interactions, which can be therapeutically effective for neuro-immune disorders and several diseases associated with neuroinflammation.
dc.identifier.citation Journal of Neuroimmunology. v.353
dc.identifier.issn 01655728
dc.identifier.uri 10.1016/j.jneuroim.2021.577501
dc.identifier.uri https://www.sciencedirect.com/science/article/abs/pii/S016557282100028X
dc.identifier.uri https://dspace.uohyd.ac.in/handle/1/7357
dc.subject Cannabinoid (CB)
dc.subject Cannabinoid Receptor (CBR)
dc.subject Endocannabinoid System (ECS)
dc.subject Immunomodulator
dc.subject Neuroimmune axis
dc.title Endocannabinoid system: Role in blood cell development, neuroimmune interactions and associated disorders
dc.type Journal. Review
dspace.entity.type
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Plain Text
Description: